FDA
approval
· 2019-12-19
FDA Approved: CONJUPRI — Original Application (CSPC Ouyi Pharmaceutical Co. Ltd)
Summary
FDA approved CONJUPRI (levamlodipine) through an Original Application by CSPC Ouyi Pharmaceutical Co. Ltd for indications including hypertension and angina.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for CONJUPRI (LEVAMLODIPINE)